- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Bristol-Myers Squibb Co
+ Add to WatchlistBMY:US
43.3000 USD 0.5300 1.24%As of 20:04:05 ET on 05/17/2013.
Snapshot for Bristol-Myers Squibb Co (BMY)
| Open: | 42.9900 | Day's Range: | 42.7000 - 43.4300 | Volume: | 11,130,086 |
|---|---|---|---|---|---|
| Previous Close: | 43.3000 | 52wk Range: | 30.6400 - 45.5900 | 1-Yr Rtn: | +37.58% |
Key Statistics for BMY
| Current P/E Ratio (ttm) | 26.7284 |
|---|---|
| Estimated P/E(12/2013) | 23.7781 |
| Relative P/E vs. SPX | 1.6382 |
| Earnings Per Share (USD) (ttm) | 1.6200 |
| Est. EPS (USD) (12/2013) | 1.8210 |
| Est. PEG Ratio | 2.8107 |
| Market Cap (M USD) | 71,122.50 |
| Shares Outstanding (M) | 1,642.55 |
| 30 Day Average Volume | 10,264,088 |
| Price/Book (mrq) | 5.1831 |
| Price/Sale (ttm) | 4.4317 |
| Dividend Indicated Gross Yield | 3.23% |
| Cash Dividend (USD) | 0.3500 |
| Last Dividend | 04/03/2013 |
| 5 Year Dividend Growth | 3.18% |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BMY
Company Profile & Key Executives for BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
| Lamberto AndreottiChief Executive Officer | Louis S SchmuklerPres:Global Manufacturing |
| Giovanni CaforioPres:US Pharmaceuticals | Charles A BancroftExec VP/CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BMY News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page